Agnieszka Żyromska1,2, Bogdan Małkowski1,3, Tomasz Wiśniewski1,4, Karolina Majewska1,5, Joanna Reszke4, Roman Makarewicz1. 1. 1 Department of Oncology and Brachytherapy, Nicolaus Copernicus University in Toruń Ludwik Rydygier, Collegium Medicum in Bydgoszcz , Bydgoszcz , Poland. 2. 2 Radiology Therapeutic Center in Krakow , Amethyst Radiotherapy Center in Zgorzelec , Poland. 3. 3 Department of Nuclear Medicine, Franciszek Lukaszczyk Oncology Centre , Bydgoszcz , Poland. 4. 4 Department of Radiotherapy, Franciszek Lukaszczyk Oncology Centre , Bydgoszcz , Poland. 5. 5 Department of Medical Physics, Franciszek Lukaszczyk Oncology Centre , Bydgoszcz , Poland.
Abstract
OBJECTIVE: Studies examining radiation-induced heart toxicity in breast cancer patients are inconclusive. The aim of this study was to prospectively and quantitatively asses myocardial blood flow (MBF) with, for the first time, 15O-H2O PET/CT as a marker of heart damage in irradiated breast cancer patients. METHODS: 15 breast cancer patients receiving intact breast or chest wall irradiation were included in the analysis (six with right-sided and nine with left-sided breast cancer). They underwent 15O-H2O PET/CT before radiotherapy (RT) and 2 and 8 months after RT. MBF was quantitatively assessed at rest and under stress conditions in 17 heart segments distinguished according to the American Ultrasound Association classification. Regional MBF values were derived in each of the coronary artery territories. RESULTS: MBF decreased in 53% and increased in 33% of cases 2 months after RT in both left-sided and right-sided breast cancer patients. Stress testing was more sensitive than at-rest testing, demonstrating decreased perfusion in the segments supplied by the left anterior descending coronary artery (LAD) [5.41 ± 1.74 vs 4.52 ± 1.82 ml (g*min)-1; p = 0.018], which persisted at 6 months [5.41 ± 1.74 vs 4.40 ± 1.38 ml (g*min)-1; p = 0.032] and a decrease in global heart perfusion [5.14 ± 1.49 vs 4.46 ± 1.73 ml (g*min)-1; p = 0.036]. A minimal radiation dose applied to the LAD correlated with MBF changes observed 2 months after RT (r = -0.57; p = 0.032). Radiological findings were not correlated with clinical symptoms of heart toxicity. CONCLUSION: 15O-H2O PET/CT is safe and effective for the early detection and quantitative analysis of subclinical post-RT changes in heart perfusion in breast cancer patients. The LV segments supplied by the LAD are the main site of MBF changes. A minimum radiation dose deposited in the LAD may be a predictor of radiation-induced heart toxicity. Advances in knowledge: This is the first time that 15O-H2O PET/CT has been used to assess MBF after RT and the first granular description of the distribution of blood flow changes after breast cancer RT.
OBJECTIVE: Studies examining radiation-induced heart toxicity in breast cancerpatients are inconclusive. The aim of this study was to prospectively and quantitatively asses myocardial blood flow (MBF) with, for the first time, 15O-H2O PET/CT as a marker of heart damage in irradiated breast cancerpatients. METHODS: 15 breast cancerpatients receiving intact breast or chest wall irradiation were included in the analysis (six with right-sided and nine with left-sided breast cancer). They underwent 15O-H2O PET/CT before radiotherapy (RT) and 2 and 8 months after RT. MBF was quantitatively assessed at rest and under stress conditions in 17 heart segments distinguished according to the American Ultrasound Association classification. Regional MBF values were derived in each of the coronary artery territories. RESULTS: MBF decreased in 53% and increased in 33% of cases 2 months after RT in both left-sided and right-sided breast cancerpatients. Stress testing was more sensitive than at-rest testing, demonstrating decreased perfusion in the segments supplied by the left anterior descending coronary artery (LAD) [5.41 ± 1.74 vs 4.52 ± 1.82 ml (g*min)-1; p = 0.018], which persisted at 6 months [5.41 ± 1.74 vs 4.40 ± 1.38 ml (g*min)-1; p = 0.032] and a decrease in global heart perfusion [5.14 ± 1.49 vs 4.46 ± 1.73 ml (g*min)-1; p = 0.036]. A minimal radiation dose applied to the LAD correlated with MBF changes observed 2 months after RT (r = -0.57; p = 0.032). Radiological findings were not correlated with clinical symptoms of heart toxicity. CONCLUSION:15O-H2O PET/CT is safe and effective for the early detection and quantitative analysis of subclinical post-RT changes in heart perfusion in breast cancerpatients. The LV segments supplied by the LAD are the main site of MBF changes. A minimum radiation dose deposited in the LAD may be a predictor of radiation-induced heart toxicity. Advances in knowledge: This is the first time that 15O-H2O PET/CT has been used to assess MBF after RT and the first granular description of the distribution of blood flow changes after breast cancer RT.
Authors: Debra A Patt; James S Goodwin; Yong-Fang Kuo; Jean L Freeman; Dong D Zhang; Thomas A Buchholz; Gabriel N Hortobagyi; Sharon H Giordano Journal: J Clin Oncol Date: 2005-09-12 Impact factor: 44.544
Authors: Katherine A Vallis; Melania Pintilie; Nelson Chong; Eric Holowaty; Pamela S Douglas; Peter Kirkbride; Andreas Wielgosz Journal: J Clin Oncol Date: 2002-02-15 Impact factor: 44.544
Authors: P H Hardenbergh; M T Munley; G C Bentel; R Kedem; S Borges-Neto; D Hollis; L R Prosnitz; L B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2001-03-15 Impact factor: 7.038
Authors: Elizabeth S Evans; Robert G Prosnitz; Xiaoli Yu; Su-Min Zhou; Donna R Hollis; Terence Z Wong; Kim L Light; Patricia H Hardenbergh; Michael A Blazing; Lawrence B Marks Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-15 Impact factor: 7.038
Authors: Sharon H Giordano; Yong-Fang Kuo; Jean L Freeman; Thomas A Buchholz; Gabriel N Hortobagyi; James S Goodwin Journal: J Natl Cancer Inst Date: 2005-03-16 Impact factor: 13.506
Authors: Ibrahim Danad; Valtteri Uusitalo; Tanja Kero; Antti Saraste; Pieter G Raijmakers; Adriaan A Lammertsma; Martijn W Heymans; Sami A Kajander; Mikko Pietilä; Stefan James; Jens Sörensen; Paul Knaapen; Juhani Knuuti Journal: J Am Coll Cardiol Date: 2014-10-07 Impact factor: 24.094
Authors: Rahul Roychoudhuri; David Robinson; Venkata Putcha; Jack Cuzick; Sarah Darby; Henrik Møller Journal: BMC Cancer Date: 2007-01-15 Impact factor: 4.430
Authors: Yevgeniy Vinogradskiy; Quentin Diot; Bernard Jones; Richard Castillo; Edward Castillo; Jennifer Kwak; Daniel Bowles; Inga Grills; Nicholas Myziuk; Thomas Guerrero; Craig Stevens; Tracey Schefter; Laurie E Gaspar; Brian Kavanagh; Moyed Miften; Chad Rusthoven Journal: Int J Radiat Oncol Biol Phys Date: 2020-01-23 Impact factor: 7.038
Authors: David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler Journal: Int J Mol Sci Date: 2022-03-30 Impact factor: 5.923